The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey

Simple item page
dc.contributor.authorMalhan S.
dc.contributor.authorPay S.
dc.contributor.authorAtaman S.
dc.contributor.authorDalkilic E.
dc.contributor.authorDinc A.
dc.contributor.authorErken E.
dc.contributor.authorErtenli I.
dc.contributor.authorErtugrul E.
dc.contributor.authorGogus F.
dc.contributor.authorHamuryudan V.
dc.contributor.authorInanc M.
dc.contributor.authorKaraaslan Y.
dc.contributor.authorKaradag O.
dc.contributor.authorKarakoc Y.
dc.contributor.authorKeskin G.
dc.contributor.authorKisacik B.
dc.contributor.authorKiraz S.
dc.contributor.authorOksel F.
dc.contributor.authorOksuz E.
dc.contributor.authorPirildar T.
dc.contributor.authorSari I.
dc.contributor.authorSoy M.
dc.contributor.authorSenturk T.
dc.contributor.authorTaylan A.
dc.date.accessioned2024-07-22T08:19:24Z
dc.date.available2024-07-22T08:19:24Z
dc.date.issued2012
dc.description.abstractObjectives: To determine the direct and indirect costs due to rheumatoid arthritis (RA) and ankylosing spondylitis (AS) patients in Turkey. Methods: An expert panel was convened to estimate the direct and indirect costs of care of patients with RA and AS in Turkey. The panel was composed of 22 experts chosen from all national tertiary care rheumatology units (n=53). To calculate direct costs, the medical management of RA and AS patients was estimated using "cost-of-illness" methodology. To measure indirect costs, the number of days of sick leave, the extent of disability, and the levels of early retirement and early death were also evaluated. Lost productivity costs were calculated using the "human capital approach", based on the minimum wage. Results: The total annual direct costs were 2,917.03 Euros per RA patient and 3,565.9 Euros for each AS patient. The direct costs were thus substantial, but the indirect costs were much higher because of extensive morbidity and mortality rates. The total annual indirect costs were 7,058.99 Euros per RA patient and 6,989.81 for each AS patient. Thus, the total cost for each RA patient was 9,976.01 Euros and that for an AS patient 10,555.72 Euros, in Turkey. Conclusion: From the societal perspective, both RA and AS have become burden in Turkey. The cost of lost productivity is higher than the medical cost. Another important conclusion is that indirect costs constitute 70% and 66% of total costs in patients with RA and AS, respectively. © Clinical and Experimental Rheumatology 2012.
dc.identifier.issn1593098X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17666
dc.language.isoEnglish
dc.subjectAbsenteeism
dc.subjectArthritis, Rheumatoid
dc.subjectCost of Illness
dc.subjectDisability Evaluation
dc.subjectHospital Costs
dc.subjectHospital Units
dc.subjectHumans
dc.subjectModels, Economic
dc.subjectPrognosis
dc.subjectRetirement
dc.subjectRheumatology
dc.subjectSick Leave
dc.subjectSpondylitis, Ankylosing
dc.subjectTurkey
dc.subjectankylosing spondylitis
dc.subjectarticle
dc.subjectcost benefit analysis
dc.subjectcost of illness
dc.subjectdeath
dc.subjectdisability severity
dc.subjectdisease course
dc.subjectdrug cost
dc.subjecthealth care cost
dc.subjecthospital cost
dc.subjecthuman
dc.subjectmedical leave
dc.subjectmorbidity
dc.subjectmortality
dc.subjectpatient care
dc.subjectpriority journal
dc.subjectproductivity
dc.subjectretirement
dc.subjectrheumatoid arthritis
dc.subjecttertiary health care
dc.subjectTurkey (republic)
dc.titleThe cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey
dc.typeArticle

Files

Collections

Scopus Koleksiyonu